Literature DB >> 7769658

The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1.

G J Sibbet1, S Cuthill, M S Campo.   

Abstract

The minimal enhancer in the long control region of human papillomavirus type 16 regulates cell type and constitutive expression from the promoter P97. This region contains at least four DNase I footprints (fp4e, fp5e, fp6e, and fp7e). We have shown that fp5e is crucial to enhancer function and have described an apparently novel factor (PEF-1) binding fp5e (S. Cuthill, G. J. Sibbet, and M. S. Campo, Mol. Carcinog. 8:9-104, 1993). Further analyses reveal that Oct-1 or an Oct-related factor binds fp5e at a site overlapping that of PEF-1. The binding of Oct-1 to fp5e has been demonstrated by electrophoretic mobility shift assays, by oligonucleotide competition studies, and by using an Oct-1-specific anti-POU serum. The location of the Oct-1 site has been confirmed by a panel of mutants across fp5e. Mutations that block PEF-1 binding to fp5e also block enhancer/promoter activity of the long control region, whereas mutations that block Oct-1 binding significantly increase enhancer/promoter activity. Thus, although both PEF-1 and Oct-1 interact with fp5e, they appear to regulate human papillomavirus expression in opposite ways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769658      PMCID: PMC189133          DOI: 10.1128/JVI.69.7.4006-4011.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.

Authors:  M Tanaka; W Herr
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

2.  Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells.

Authors:  F X Bosch; E Schwarz; P Boukamp; N E Fusenig; D Bartsch; H zur Hausen
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer.

Authors:  B Gloss; T Chong; H U Bernard
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element.

Authors:  M O'Connor; H U Bernard
Journal:  Virology       Date:  1995-02-20       Impact factor: 3.616

6.  Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites.

Authors:  W K Chan; T Chong; H U Bernard; G Klock
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

7.  Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.

Authors:  T Chong; W K Chan; H U Bernard
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

8.  A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter.

Authors:  E A Offord; P Beard
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

9.  Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function.

Authors:  B Gloss; M Yeo-Gloss; M Meisterenst; L Rogge; E L Winnacker; H U Bernard
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

10.  Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene.

Authors:  T H Haugen; T P Cripe; G D Ginder; M Karin; L P Turek
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

View more
  7 in total

1.  Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia.

Authors:  K J Watts; C H Thompson; Y E Cossart; B R Rose
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  CCAAT displacement protein, a regulator of differentiation-specific gene expression, binds a negative regulatory element within the 5' end of the human papillomavirus type 6 long control region.

Authors:  S Pattison; D G Skalnik; A Roman
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.

Authors:  W Zhao; L T Chow; T R Broker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  The role of oct-1 in the regulation of tracheal antimicrobial peptide (TAP) and lingual antimicrobial peptide (LAP) expression in bovine mammary epithelial cells.

Authors:  Jun Yang; Yongming Sang; Kieran G Meade; Chris Ross
Journal:  Immunogenetics       Date:  2011-06-15       Impact factor: 2.846

5.  A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.

Authors:  K W Vance; M S Campo; I M Morgan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism.

Authors:  John H Lee; Su Min P Yi; Mary E Anderson; Kristi L Berger; Michael J Welsh; Aloysius J Klingelhutz; Michelle A Ozbun
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

7.  Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.

Authors:  Shailja Pande; Neeraj Jain; Bhupesh K Prusty; Suresh Bhambhani; Sanjay Gupta; Rajyashri Sharma; Swaraj Batra; Bhudev C Das
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.